FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: NIDA

  • Home
  •  | 
  • Tag Archives: "NIDA"

Columbia University Receives National Institute on Drug Abuse (NIDA) Research Grant to Study Impact of Medical Cannabis on Opioid Use in Collaboration with Columbia Care

Columbia University Receives National Institute on Drug Abuse (NIDA) Research Grant to Study Impact of Medical Cannabis on Opioid Use in Collaboration with Columbia Care
The Columbia University Department of Psychiatry and Columbia Care LLC, the nation’s leading medical cannabis company, today announced that researchers from Columbia University have been awarded an R21 research grant from the National Institute on Drug Abuse (NIDA) to study, in collaboration with Columbia Care, the potential mechanisms of how using Columbia Care’s formulated dose-metered cannabinoid medicines influences opioid use and overdose risk among patients with non-cancer pain conditions.
Read more

Cannabinoids May Do More Than Manage Cancer Symptoms — CFN Media

Cannabinoids May Do More Than Manage Cancer Symptoms — CFN Media
The liberalization of cannabis laws around the world has opened the door for researchers to explore the therapeutic benefits of cannabinoids. While GW Pharmaceuticals plc (NASDAQ:GWPH) has already launched products targeting epilepsy and spasticity in Multiple Sclerosis, emerging research suggests that they could play a role in treating many types of cancers.
Read more